Release Date: 03/10/14 15:06 Summary: Final / Initial Director's Interest Notice Price Sensitive: No Download Document 243.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%